The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country
Tóm tắt
As the most populated Persian Gulf country in West Asia, methamphetamine use in methadone maintenance treatment (MMT) is a new health concern in Iran. Methamphetamine use in MMT can originate in methadone misconceptions or the stimulant effects of methamphetamine use. Several research studies have highlighted the prevalence of methamphetamine use in Iran and conducting further studies on this issue is being developed. Opiate use is treated with MMT. But, there is no effective pharmacological treatment for methamphetamine use and cognitive-behavioral interventions have still remained the best practice. As a psychostimulant drug, methamphetamine use can lead to poor treatment outcomes or even treatment failure among patients in MMT. Therefore, the implementation of methamphetamine education and prevention programs in MMT is required. Prescribing adequate methadone dose and the treatment of comorbidities as well as, doing a series of activities outside treatment is underscored. Methamphetamine use has a chronic nature and methamphetamine treatment is a long-term procedure with a high rate of relapse. Therefore, the implementation of long-term motivational interviewing, teaching necessary skills to prevent relapse and case management is highlighted. A long-term collaboration between treatment teams, patients and their families is suggested to manage methamphetamine use in MMT.
Tài liệu tham khảo
Degenhardt L, Baxter AJ, Lee YY, Hall W, Grant ES, Johns N, et al. The global epidemiology and burden of psychostimulant dependence: findings from the global burden of disease study 2010. Drug Alcohol Depend. 2014;137:36–44.
Alam-mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:78–83. http://dx.doi:10.1016/j.ajp.2015.06.002.
Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: a systematic review from the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:17–25. http://dx.doi:10.1016/j.ajp.2015.05.036.
Alam Mehrjerdi Z. Crystal in Iran: methamphetamine or heroin Kerack. Daru. 2013;21:22. http://dx.doi:10.1186/2008-2231-21-22.
Shariatirad S, Maarefvand M, Ekhtiari H. Emergence of a methamphetamine crisis in Iran. Drug Alcohol Rev. 2013;32:223–4. http://dx.doi:10.1111/dar.12014.
Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013;24:e115–6.
Kharabaf S, Abdollahi M. Science growth in Iran over the past 35 years. J Res Med Sci. 2012;17(3):1–5.
Jafari S, Noroozi A, Razzaghie EM, Shafiee SA, Naghshvarian M. How to address methamphetamine involvement in OST settings. Harm Reduction’s 22ND International Conference, Beirut: Lebanon, 2011. http://www.ihra.net/files/2011/05/03/HR2011_Programme.pdf. Accessed 11 June 2014.
Lashkaripour K, Torbati E. Methamphetamine dependence. Int J High Risk Behav Addict. 2012;1:7–8. http://dx.doi:10.5812/ijhrba.5336.
Hojjat SK, Golmakanie E, Erfanian Majid R, Khajedaluee M, Norouzi Khalili M, Ebrahimi Sani E. A comparison of demographic characteristics of men and women under agonist maintenance treatment in North Khorasan province. 8th Addiction Science Conference, Tehran: Iran, 2014. http://www.aimjournal.ir/LinkClick.aspx?fileticket=VQ9VAnBZ-zw%3d&tabid=85. Accessed 21 November 2014.
Ahounbar E, Dolatshahi B, Farhoudian A. Role of abuse in lapse, during methadone maintenance treatment (MMT). 8th Addiction Science Conference, Tehran: Iran, 2014. http://www.aimjournal.ir/LinkClick.aspx?fileticket=VQ9VAnBZ-zw%3d&tabid=85. Accessed 21 November 2014.
Ghane M, Pourhashemi SJ, Jafari A, Shekarchizadeh H. Oral health and dental treatment needs status of in-treatment drug addicted women. 8th Addiction Science Conference, Tehran: Iran, 2014. http://www.aimjournal.ir/LinkClick.aspx?fileticket=VQ9VAnBZ-zw%3d&tabid=85. Accessed 21 November 2014.
Oraki M, Mokri A, Kiaei S. Relationship between craving for methamphetamine and personality characteristics among patients in methadone maintenance treatment program. Iran J Psychiatry Clin Psychol. 2014;19:177–86.
Daneshmand R, Shishegar S, Alam mehrjerdi Z, Fathy Z. The psychological problems of female co-users of opiates with methamphetamine: implications for longer treatment retention. 8th Addiction Science Conference, Tehran: Iran, 2014. http://www.aimjournal.ir/LinkClick.aspx?fileticket=VQ9VAnBZ-zw%3d&tabid=85. Accessed 21 November 2014.
Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology and treatment literature. Drug Alcohol Depend. 2014;143:11–21.
Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacol. 2014;87:150–60.